Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day

BACKGROUND: Efficacy and safety profiles by sex and age (6-9 vs 10-12 years) and magnitude and duration of effect by effect size overall and across the day of lisdexamfetamine dimesylate (LDX) vs placebo were assessed. METHODS: This study enrolled children (6-12 years) with attention-deficit/hyperac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wigal, Sharon B, Kollins, Scott H, Childress, Ann C, Adeyi, Ben
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022598/
https://www.ncbi.nlm.nih.gov/pubmed/21156071
http://dx.doi.org/10.1186/1753-2000-4-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022598/
https://www.ncbi.nlm.nih.gov/pubmed/21156071
http://dx.doi.org/10.1186/1753-2000-4-32

Ejemplares similares